Stock 300871 HVSEN BIOTECHNOLOGY CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Hvsen Biotechnology Co., Ltd.

Equities

300871

CNE1000047H6

End-of-day quote Shenzhen S.E.
Other stock markets
 23:00:00 23/05/2024 BST 		5-day change 1st Jan Change
14.43 CNY -0.62% Intraday chart for Hvsen Biotechnology Co., Ltd. -6.60% -0.21%
04-25 Hvsen Biotechnology Co., Ltd. Proposes Final Cash Dividend for 2023 CI
04-24 Hvsen Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Summary

  • Overall, the company has poor fundamentals for a medium to long-term investment strategy.

Strengths

  • The prospective high growth for the next fiscal years is among the main assets of the company
  • The company's profit outlook over the next few years is a strong asset.
  • Analysts covering this company mostly recommend stock overweighting or purchase.

Weaknesses

  • With a 2024 P/E ratio at 35.63 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
  • For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
  • The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
  • For the past year, analysts have significantly revised downwards their profit estimates.
  • For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
  • The group usually releases earnings worse than estimated.

Ratings chart - Surperformance

Sector: Pharmaceuticals

1st Jan change Capi. Investor Rating ESG Refinitiv
HVSEN BIOTECHNOLOGY CO., LTD. Stock Hvsen Biotechnology Co., Ltd.
-0.21% 328M -
ZOETIS INC. Stock Zoetis Inc.
-13.38% 77.98B
B+
BLUESTAR ADISSEO COMPANY Stock Bluestar Adisseo Company
+24.00% 3.66B
B-
VIRBAC Stock Virbac
+0.14% 3.26B
B-
VIMIAN GROUP AB Stock Vimian Group AB
+14.70% 1.63B -
JINYU BIO-TECHNOLOGY CO., LTD. Stock Jinyu Bio-technology Co., Ltd.
-4.46% 1.6B
B
VETOQUINOL SA Stock Vetoquinol SA
+2.54% 1.34B -
CHINA ANIMAL HUSBANDRY INDUSTRY CO., LTD. Stock China Animal Husbandry Industry Co., Ltd.
-22.01% 1.31B
C-
WUHAN KEQIAN BIOLOGY CO.,LTD Stock Wuhan Keqian Biology Co.,Ltd
-12.12% 1.18B -
PULIKE BIOLOGICAL ENGINEERING, INC. Stock Pulike Biological Engineering, Inc.
+1.55% 1.11B -
Investor Rating
Trading Rating
-
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
-
Profitability
Finances
-

Valuation

P/E ratio
EV / Sales
-
Price to Book
Price to Free Cash Flow
-
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
-
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. 300871 Stock
  4. Ratings Hvsen Biotechnology Co., Ltd.